Alvotech Reiterates Meeting US Humira Biosimilar Launch Date
As Partner Cipla Bags Australian Approval For AVT02 Adalimumab Asset
Recently public Alvotech had much to share as part of its nine-month financial report, including updates on adalimumab in the US and the process to begin biosimilar golimumab trials.
